Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
NCT ID: NCT03813017
Last Updated: 2019-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2019-10-31
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rheumatoid Arthritis Disease Activity and Sub Clinical Atherosclerosis
NCT03821090
Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study
NCT03776682
Atherosclerosis in Rheumatoid Arthritis
NCT00037336
Atherosclerosis in Rheumatoid Arthritis
NCT00990730
Cardiovascular Risk and Chronic Inflammatory Rheumatism
NCT03187444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Absence of established CVD:
* Myocardial Infarction p/h
* PCI with balloon and/or stent
* Intermittent claudication
* PAD / intervention
* CAS /intervention
3. Signed informed consent form
4. Documented diagnosis of rheumatoid arthritis
Exclusion Criteria
2. Pregnancy
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziv Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osamah Hussein
Head of Internal Medicine A
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0123-18-ZIV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.